China Blood Testing (Typing, Immunoassay, NAT Testing) Market Overview 2016-2020 - Research and Markets

News provided by

Research and Markets

27 May, 2016, 20:10 GMT

DUBLIN, May 27, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Blood Testing Market in China (Typing, Immunoassay, NAT Testing)" report to their offering.

With a population of more than 1 billion, China is the world's largest country and therefore also its single largest potential market for goods and services. Blood Testing Market in China offers the most current look at the blood testing IVD market in China, including tests for blood typing, immunoassay-based tests and NAT Tests.

The report provides market analysis and data on the blood testing market environment in China, including:

  • Blood Center Stations in China by Type (Provincial, Regional, County, Cord, Plasma, Other)
  • China Blood Supply Statistics
  • Blood Supply Centers in Beijing
  • Blood Supply in China (tons)
  • Blood Supply in China (tons) by Type (Voluntary Unpaid Blood Donation/Paid Plasma Donation)
  • Blood Testing Market in China (Typing, Immunoassay, NAT), 2015 and 2020
  • Progress of Conversion (Provincial, Regional, County, Plasma Collection) Percentage Using NAT Testing

Blood Testing Market in China profiles companies in the market and speculates on the best opportunities for test makers. Companies profiled include:

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • DiaSorin
  • Grifols

Key Topics Covered:

CHAPTER ONE: EXECUTIVE SUMMARY

Overview

Chinese Healthcare and Blood Banking Environment

Scope and Methodology

Blood Testing Market in China

Major Findings of the Report

CHAPTER TWO: INTRODUCTION

Population Trends and Disease Demographics

Regulation and Policy Challenges for International Companies

CHAPTER THREE: BLOOD TESTING MARKET ENVIRONMENT IN CHINA

Tests Used in Blood Banking

Nucleic-Acid Testing (NAT)

Immunoassays

Typing

Blood Donation and Facilities Data for Specific Provinces

CHAPTER FOUR: MARKET ANALYSIS

Market Overview

CHAPTER FIVE: COMPANY PROFILES

Abbott Laboratories

Bio-Rad Laboratories, Inc.

DiaSorin

Grifols

Immucor

Ortho Clinical Diagnostics

PerkinElmer

Roche

China Health Labs & Diagnostics, Ltd.

Daan Gene Co., Ltd.

For more information visit http://www.researchandmarkets.com/research/czr7sv/blood_testing

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com